CRISPR Therapeutics
CRSP
$55.65
Share price
-1.35%
Change (1 day)
8.95%
Change (1 year)
CRISPR Therapeutics (CRSP) - Total assets
Total assets on the balance sheet as of December 2023 : $2.22 B
According to CRISPR Therapeutics's latest financial reports the company's total assets are $2.22 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
CRISPR Therapeutics - Total assets on balance sheet (from 2015 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $2.22 B | -0.6% |
| 2022-12-31 | $2.24 B | -18.49% |
| 2021-12-31 | $2.75 B | 50.54% |
| 2020-12-31 | $1.82 B | 71.36% |
| 2019-12-31 | $1.06 B | 118.14% |
| 2018-12-31 | $0.48 B | 80.22% |
| 2017-12-31 | $0.27 B | -21.34% |
| 2016-12-31 | $0.34 B | 116.38% |
| 2015-12-31 | $0.15 B | 10340.28% |
| 2014-12-31 | $1.52 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.25 B | -88.70% | 🇺🇸 USA |